DC-SIGN mediated antigen-targeting using glycan-modified liposomes: formulation considerations.

  • M.D. Joshi
  • , W.W.J. Unger
  • , A.J. van Beelen
  • , S.C.M. Bruijns
  • , M. Litjens
  • , L. van Bloois
  • , H. Kalay
  • , Y. van Kooyk
  • , G. Storm

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Dendritic cells (DCs) are key antigen presenting cells that have the unique ability to present antigens on MHC molecules, which can lead to either priming or suppression of T cell mediated immune responses. C-type lectin receptors expressed by DCs are involved in antigen uptake and presentation through recognition of carbohydrate structures on antigens. Here we have explored the feasibility of modification of liposomes with glycans for targeting purposes to boost immune responses. The potential of targeting glycoliposomal constructs to the C-type lectin DC-SIGN on DCs was studied using either PEGylated or non-PEGylated liposomes. Our data demonstrate that formulation of the glycoliposomes as PEGylated negatively affected their potential to target to DCs.
Original languageUndefined/Unknown
Pages (from-to)426-32
Number of pages7
JournalInternational Journal of Pharmaceutics
Volume416
Issue number2
Publication statusPublished - 2011

Keywords

  • Farmacie/Biofarmaceutische wetenschappen (FARM)
  • Medical technology
  • Farmacie(FARM)
  • Biomedische technologie en medicijnen
  • Pharmacology

Cite this